This site is intended for health professionals only

Editor’s pick

Drug firm brings jobs to Ireland
Drug firm brings jobs to Ireland
CHMP recommends marketing authorisation for Firmagon
CHMP recommends marketing authorisation for Firmagon
Lundbeck initiates new trial
Lundbeck initiates new trial
Exemestane “reduces bone density”
Exemestane “reduces bone density”
Olive oil hope for breast cancer
Olive oil hope for breast cancer
Lundbeck initiate phase III programme to treat acute stroke
Lundbeck initiate phase III programme to treat acute stroke
FDA approval for Genzyme’s Mozobil
FDA approval for Genzyme’s Mozobil
Dual therapy improves cancer prognosis
Dual therapy improves cancer prognosis
Robot dispensers at city hospitals
Robot dispensers at city hospitals
European healthcare talks launched
European healthcare talks launched
Arpida implements comprehensive action plan
Arpida implements comprehensive action plan
Lundbeck initiates phase III trial with nalmefene
Lundbeck initiates phase III trial with nalmefene
1 … 159 160 161 162 163 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x